⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ABBV News
ABBVIE INC.
Conjunctivitis Market to Reach $61.6 Billion by 2033 Globally, at 13.8% CAGR: Allied Market Research
prnewswire.com
ABBV
JNJ
BHC
NVS
Genmab Publishes 2025 Annual Report
globenewswire.com
GMAB
HALO
ABBV
MRUS
NVS
JNJ
HRZN
Facial Injectable Analysis Report 2025: An $18.89 Billion Market by 2029, Driven by New Product Launches, Emerging Markets, AI Innovations, Male Aesthetics, Younger Demographics
globenewswire.com
ABBV
Leading the Next Wave of Innovative IBD Therapeutics Targeting Immunometabolism: Josep Bassaganya-Riera Launches Clinical Program and Business Venture to Develop NIM-1324 for Ulcerative Colitis and Crohn’s disease
businesswire.com
ABBV
Atopic Dermatitis Market to Accelerate at a Rapid Pace by 2034 with Advancements in Biologics and JAK Inhibitors | DelveInsight
prnewswire.com
AMGN
CNTB
NKTR
APGE
LLY
OGN
ABBV
PFE
REGN
INCY
IPSC-derived NK Cells Clinical Trial Pipeline Gains Momentum: 12+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
globenewswire.com
FATE
INDP
AMGN
NKTR
IBIO
TAK
SNY
INMB
CLMT
VERX
GTBP
BHVN
CHRS
GSK
BMY
MRK
ABBV
AZN
GILD
LLY
KYMR
REGN
SPRY
Sensing Local Fibers in Pancreatic Tumors, Cancer Cells 'Choose' to Either Grow or Tolerate Treatment
prnewswire.com
ABBV
Culinary Tourism Market Analysis Report 2026: $2.19 Trillion Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
ABBV
World-First EXO 001 Exosome Platform Enables In Vivo Multi-Target CAR-T for Solid Tumors
prnewswire.com
GILD
AZN
BMY
ABBV
Nxera Pharma Operational Highlights and Consolidated Results for the Fourth Quarter and Full Year 2025
globenewswire.com
ABBV
LLY